Original Research

Three-year outcome analysis of alpha 1-blocker naftopidil for patients with benign prostatic hyperplasia in a prospective multicenter study in Japan

Masumori N, Tsukamoto T, Shibuya A, Miyao N, Kunishima Y, Iwasawa A

Patient Preference and Adherence 2016, 10:1309-1316

Published Date: 22 July 2016